Learn More
Medchemexpress LLC Myristicin | 607-91-0 | 25 MG

Supplier: Medchemexpress LLC 25MGHYN2510
Myristicin is an orally bioavailable serotonin receptor antagonist and a weak monoamine oxidase (MAO) inhibitor. It exhibits anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. As the primary component of nutmeg essential oil, Myristicin possesses anti-cancer, anti-proliferative, antibacterial, anti-inflammatory, and apoptosis-inducing properties.
- Orally bioavailable serotonin receptor antagonist
- Weak monoamine oxidase (MAO) inhibitor
- Inhibits EGFR/ERK signaling pathway
- Main component of nutmeg essential oil
- Exhibits anti-cancer, anti-proliferative, antibacterial, and anti-inflammatory properties
- Induces apoptosis in gastric cancer cells
- Reduces cell cycle protein expression
- Increases Bax expression and activates caspase enzyme
- Targets EGFR, ERK, and 5-HT Receptor
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.